Research/ Academia/ Activities
Research program to elucidate the molecular bio...
Shinko Pharmaceutical Co., Ltd. (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) has launched a series of life science research programs focusing on the mechanism of action and effects of Nicotinamide Mononucleotide...
Research program to elucidate the molecular bio...
Shinko Pharmaceutical Co., Ltd. (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) has launched a series of life science research programs focusing on the mechanism of action and effects of Nicotinamide Mononucleotide...